Oncology Innovations TNBC: Bridging Gaps in Care for the Black Community
Released On
August 15, 2025
Expires On
November 26, 2025
Media Type
Internet
Completion Time
60 minutes
Specialty
Hematology-Oncology
Topic(s)
Breast Cancer, Oncology
Providers/Grant Support
Jointly provided by Partners for Advancing Clinical Education (PACE) and DKBmed, LLC.
This activity is supported by an independent educational grant from Gilead Sciences, Inc.
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit™
- Nurses — 1.0 Nursing Contact Hour
- Physician Assistants — 1.0 AAPA Category 1 CME Credit
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
The intended audience for this Clinician Webcast will be physicians, physician assistants, nurse practioners, and registered nurses.
Program Overview
Triple-negative breast cancer presents unique challenges and an urgent need for effective, personalized therapies. Treating advanced TNBC requires a deep understanding of:
- Biomarker testing
- Immunotherapy
- PARP inhibitors
- Antibody-drug conjugates
Join our free CME/CE webinar as we dive into recent advancements in TNBC treatment, presenting practical case studies and the latest data on managing treatment-related adverse events.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Discuss the evidence supporting molecular testing in advanced TNBC.
- Assess the efficacy of treatment options for those with mTNBC.
- Apply best practices for managing TRAEs associated with therapies for mTNBC.
Faculty
Rita Nanda, MD
Director of Breast Oncology
Associate Professor of Medicine
University of Chicago
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and DKBmed LLC. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Physician Continuing Education
PACE designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.
PA Continuing Medical Education
PACE has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until 11/26/25. PAs should only claim credit commensurate with the extent of their participation.
Disclosures of Conflicts of Interest
Rita Nanda, MD
- Consultant, Advisor, Speaker: Astrazeneca, Daiichi Sankyo, Exact Sciences, GE, Gilead, Guardant Health, Merck, Moderna, Novartis, OBI, Pfizer, Sanofi, Seagen, Stemline, Summit Therapeutics
- Researcher: Arvinas, AstraZeneca, BMS, Corcept Therapeutics, Genentech/Roche, Gilead, GSK, Merck, Novartis, OBI Pharma, Pfizer, Relay, Seattle Genetics, Sun Pharma, Taiho
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be available for the participant to download.
Course Viewing Requirements
To access activities, users will need:
- A computer with an internet connection
- An HTML5 compliant web browser or Internet Explorer 8 (and higher)
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
There are no fees for participating and receiving CME/CE credit for this activity.
Contact Information
For additional information about the accreditation of this activity, please visit https://partnersed.com